DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
DRI Healthcare Trust (DHT-U) - Net Assets
Latest net assets as of June 2025: $503.60 Million USD
Based on the latest financial reports, DRI Healthcare Trust (DHT-U) has net assets worth $503.60 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($967.26 Million) and total liabilities ($463.66 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $503.60 Million |
| % of Total Assets | 52.06% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 25.85 |
DRI Healthcare Trust - Net Assets Trend (2020–2024)
This chart illustrates how DRI Healthcare Trust's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for DRI Healthcare Trust (2020–2024)
The table below shows the annual net assets of DRI Healthcare Trust from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $527.53 Million | -6.05% |
| 2023-12-31 | $561.50 Million | +50.80% |
| 2022-12-31 | $372.34 Million | -1.75% |
| 2021-12-31 | $378.99 Million | +107666293.18% |
| 2020-12-31 | $-352.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to DRI Healthcare Trust's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2714163800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $554.67 Million | 105.15% |
| Total Equity | $527.53 Million | 100.00% |
DRI Healthcare Trust Competitors by Market Cap
The table below lists competitors of DRI Healthcare Trust ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Genting Plantations Bhd
KLSE:2291
|
$450.53 Million |
|
Guangdong Wencan Die Casting Co Ltd
SHG:603348
|
$450.58 Million |
|
Honasa Consumer Limited
NSE:HONASA
|
$450.68 Million |
|
Gevo Inc
NASDAQ:GEVO
|
$450.69 Million |
|
Tinexta S.p.A.
LSE:0RIW
|
$450.40 Million |
|
COOR Service Management AB
ST:COOR
|
$450.36 Million |
|
DCM Shriram Limited
NSE:DCMSHRIRAM
|
$450.11 Million |
|
The Hongkong and Shanghai Hotels Limited
F:HSG
|
$449.80 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DRI Healthcare Trust's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 561,497,000 to 527,531,000, a change of -33,966,000 (-6.0%).
- Net loss of 3,364,000 reduced equity.
- Dividend payments of 33,598,000 reduced retained earnings.
- Share repurchases of 3,917,000 reduced equity.
- New share issuances of 20,441,000 increased equity.
- Other comprehensive income decreased equity by 1,060,999.
- Other factors decreased equity by 12,467,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.36 Million | -0.64% |
| Dividends Paid | $33.60 Million | -6.37% |
| Share Repurchases | $3.92 Million | -0.74% |
| Share Issuances | $20.44 Million | +3.87% |
| Other Comprehensive Income | $-1.06 Million | -0.2% |
| Other Changes | $-12.47 Million | -2.36% |
| Total Change | $- | -6.05% |
Book Value vs Market Value Analysis
This analysis compares DRI Healthcare Trust's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.25x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.07x to 1.25x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $10.94 | $11.68 | x |
| 2022-12-31 | $9.65 | $11.68 | x |
| 2023-12-31 | $12.58 | $11.68 | x |
| 2024-12-31 | $9.37 | $11.68 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DRI Healthcare Trust utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.64%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.41%
- • Asset Turnover: 0.14x
- • Equity Multiplier: 1.87x
- Recent ROE (-0.64%) is below the historical average (4.92%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.14K |
| 2021 | 5.69% | 29.40% | 0.17x | 1.15x | $-16.34 Million |
| 2022 | 3.11% | 14.52% | 0.13x | 1.70x | $-25.64 Million |
| 2023 | 16.44% | 42.34% | 0.26x | 1.49x | $36.15 Million |
| 2024 | -0.64% | -2.41% | 0.14x | 1.87x | $-56.12 Million |
Industry Comparison
This section compares DRI Healthcare Trust's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $115,724,252
- Average return on equity (ROE) among peers: -337.40%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DRI Healthcare Trust (DHT-U) | $503.60 Million | 0.00% | 0.92x | $450.44 Million |
| Amotiv Limited (AOV) | $1.03 Billion | 2.34% | 0.02x | $227.15 Million |
| Cannabist Company Holdings Inc (CBST) | $-986.97K | 0.00% | 0.00x | $11.81 Million |
| GenixPharmaceucticals Corporation (GENX) | $4.01 Million | -41.17% | 0.19x | $451.93K |
| Simply Solventless Concentrates Ltd. (HASH) | $1.78 Million | -130.46% | 0.98x | $2.35 Million |
| The Hempshire Group Corp. (HMPG) | $-835.46K | 0.00% | 0.00x | $515.15K |
| LSL Pharma Group Inc. (LSL) | $7.48 Million | 1.18% | 2.18x | $23.20 Million |
| Good Shroom Co Inc (MUSH) | $242.01K | -170.37% | 3.22x | $3.09 Million |
| Navasota Resources Inc. (NAV) | $3.47K | -2698.16% | 31.31x | $132.92K |
| Verano Holdings Corp Ordinary Shares - Class A (Sub Voting) (VRNO) | $-216.50K | 0.00% | 0.00x | $303.72 Million |